Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03048279 · ClinicalTrials.gov registry record
Registry for Multiple Endocrine Neoplasia Syndromes: MEN1/MEN2
A clinical trial of Multiple Endocrine Neoplasia Syndromes, sponsored by M.D. Anderson Cancer Center.
- Active
- Registry status
- 1,500
- Enrollment target
- 1
- Study location
NCT03048279 is a study of Multiple Endocrine Neoplasia Syndromes that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 1,500 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03048279, a study of Multiple Endocrine Neoplasia Syndromes, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- 1,500 participants
- Enrollment target
- 1
- Study location
Study Summary
Objectives: To contribute new and prospective data to our existing database library for patients with MEN1 and MEN2 at The University of Texas M.D. Anderson Cancer Center.
Conditions Studied
Interventions
- BEHAVIORAL Questionnaires
Study Locations (1)
Texas
- University of Texas MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,500 participants |
| Start Date | 2001-09-05 |
| Est. Completion | 2026-09-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03048279
The ClinicalTrials.gov registry entry for NCT03048279 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 1,500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Multiple Endocrine Neoplasia Syndromes appearing as the primary indexed condition, and to 1 intervention - of which Questionnaires is the first listed.
NCT03048279 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT03048279 about?
NCT03048279 is a clinical study titled "Registry for Multiple Endocrine Neoplasia Syndromes: MEN1/MEN2". Objectives: To contribute new and prospective data to our existing database library for patients with MEN1 and MEN2 at The University of Texas M.D. Anderson Cancer Center.
What is the current status of trial NCT03048279?
This trial is currently active not recruiting. The enrollment target is 1,500 participants. The study started on 2001-09-05. Estimated completion is 2026-09-01.
What conditions does trial NCT03048279 study?
This clinical trial studies the following conditions: Multiple Endocrine Neoplasia Syndromes.
What interventions are being tested in trial NCT03048279?
The interventions under investigation include: Questionnaires (BEHAVIORAL).
Who is sponsoring clinical trial NCT03048279?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03048279 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.